Lipid nanoparticles are enabling a new generation of engineered cell therapies with a push toward more complex cell engineering and gene editing for allogeneic therapies.
Gene delivery platforms need to support a diversity of genetic engineering strategies for the development of genomic medicines. Read more about how lipid nanoparticles can accelerate development from discovery to scale-up.
Read this article to learn more about the key stages of drug discovery and screening, and how to overcome key bottlenecks in screening mRNA-LNPs to rapidly develop genomic medicines.
Speed to market is critical but the path to developing a commercial mRNA-lipid nanoparticle (LNP) drug product is complex with challenges at every stage. Learn why single-use technology is gaining attention for its ability to facilitate a reliable and robust manufacturing process for biopharma manufacturers looking to scale up mRNA therapeutics.
Join us on December 7, 2023 for Precision NanoSystems' Symposium, a virtual event to explore how mRNA-lipid nanoparticles can revolutionize cell and gene therapies. This live event features scientific experts and industry leaders who will share insights into ongoing novel research and the exceptional potential of mRNA-lipid nanoparticles in gene-modified cell therapies, vaccines, pulmonary delivery, and more! Register.
This website uses cookies to ensure you get the best experience on our website. Learn more
